PRF Technologies (PRFX) Non-cash Items (2019 - 2020)
PRF Technologies (PRFX) recorded quarterly Non-cash Items of $651000.0 in Q4 2020, up 323.05% on a QoQ basis from $153882.0 in Q4 2019, and up 323.05% year-over-year from $153882.0 in Q1 2020.
PRF Technologies (PRFX) Non-cash Items (2019 - 2020) Analysis & Trends
PRF Technologies has disclosed Non-cash Items across 2 years of filings, most recently posting $651000.0 for Q4 2020.
- Quarterly Non-cash Items rose 323.05% year-over-year to $651000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $651000.0 (up 323.05% YoY) and the FY2020 annual result came in at $651000.0, up 323.05% from the prior year.
- Non-cash Items grew to $651000.0 in Q4 2020, from $153882.0 in the prior quarter.
- Over five years, Non-cash Items peaked at $651000.0 in Q4 2020 and troughed at $153882.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 651,000.00 |
| Dec 31, 2020 | 651,000.00 |
| Dec 31, 2019 | 153,882.00 |
| Dec 31, 2019 | 153,882.00 |